Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 741,281 $ 843,952
Premium and related receivables 355,947 263,452
Short-term investments 122,631 139,118
Other current assets 148,576 127,080
Total current assets 1,368,435 1,373,602
Long-term investments 816,910 614,723
Restricted deposits 40,911 34,793
Property, software and equipment, net 390,200 377,726
Goodwill 347,548 256,288
Intangible assets, net 50,541 20,268
Other long-term assets 124,492 64,282
Total assets 3,139,037 2,741,682
Current liabilities:    
Medical claims liability 1,071,672 926,302
Premium deficiency reserve 0 41,475
Accounts payable and accrued expenses 270,381 191,343
Unearned revenue 41,873 34,597
Current portion of long-term debt 3,046 3,373
Total current liabilities 1,386,972 1,197,090
Long-term debt 517,931 535,481
Other long-term liabilities 49,043 55,344
Total liabilities 1,953,946 1,787,915
Commitments and contingencies      
Stockholders' equity:    
Common stock, $.001 par value; authorized 100,000,000 shares; 57,872,798 issued and 54,767,551 outstanding at September 30, 2013, and 55,339,160 issued and 52,329,248 outstanding at December 31, 2012 58 55
Additional paid-in capital 578,188 450,856
Accumulated other comprehensive income:    
Unrealized (loss) gain on investments, net of tax (1,845) 5,189
Retained earnings 678,679 566,820
Treasury stock, at cost (3,105,247 and 3,009,912 shares, respectively) (75,541) (69,864)
Total Centene stockholders' equity 1,179,539 953,056
Noncontrolling interest 5,552 711
Total stockholders' equity 1,185,091 953,767
Total liabilities and stockholders' equity $ 3,139,037 $ 2,741,682